N. Miyawaki

发表

J. Mattana, A. Reiss, I. Voloshyna, 2015, American journal of kidney diseases : the official journal of the National Kidney Foundation.

CKD, arterial calcification, atherosclerosis and bone health: Inter-relationships and controversies.

L. Kasselman, A. Reiss, I. Voloshyna, 2018, Atherosclerosis.

Ontogeny of flow-stimulated potassium secretion in rabbit cortical collecting duct: functional and molecular aspects.

L. Satlin, R. Rojas, C. Woda, 2003, American journal of physiology. Renal physiology.

COVID-19 Antibodies and Outcomes among Outpatient Maintenance Hemodialysis Patients.

J. Divers, L. Imbriano, Minesh Khatri, 2020, Kidney360.

Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges

S. Shirazian, N. Miyawaki, V. Mathur, 2017, International journal of nephrology and renovascular disease.

Characteristics of human immunodeficiency virus and chlorpromazine induced antiphospholipid antibodies: effect of beta 2 glycoprotein I on binding to phospholipid.

M. Lockshin, L. Sammaritano, A. Gharavi, 1994, The Journal of rheumatology.

Complexity of Differentiating Cerebral-Renal Salt Wasting from SIADH, Emerging Importance of Determining Fractional Urate Excretion

S. Shirazian, J. Maesaka, L. Imbriano, 2012 .

The effect of ergocalciferol on uremic pruritus severity: a randomized controlled trial.

S. Fishbane, Samiran Ghosh, S. Shirazian, 2013, Journal of renal nutrition : the official journal of the Council on Renal Nutrition of the National Kidney Foundation.

Prostaglandin D2 synthase: Apoptotic factor in alzheimer plasma, inducer of reactive oxygen species, inflammatory cytokines and dialysis dementia.

L. Ragolia, M. El-Sabban, V. Batuman, 2013, Journal of nephropathology.

Cerebral–Renal Salt Wasting

S. Shirazian, J. Maesaka, L. Imbriano, 2013 .

Mild Nephrogenic Diabetes Insipidus Caused by Foxa1 Deficiency*

K. Kaestner, J. Fulmer, R. Behr, 2004, Journal of Biological Chemistry.

Fellows’ Forum in Dialysis   edited by Mark A. Perazella: A Patient With an Uncommon Etiology of Intradialytic Hypotension

J. Maesaka, N. Miyawaki, Naveed N. Masani, 2005, Seminars in dialysis.

Evolution and evolving resolution of controversy over existence and prevalence of cerebral/renal salt wasting.

J. Maesaka, L. Imbriano, N. Miyawaki, 2020, Current opinion in nephrology and hypertension.

Determining Fractional Urate Excretion Rates in Hyponatremic Conditions and Improved Methods to Distinguish Cerebral/Renal Salt Wasting From the Syndrome of Inappropriate Secretion of Antidiuretic Hormone

J. Maesaka, L. Imbriano, N. Miyawaki, 2018, Front. Med..

High Prevalence of Renal Salt Wasting Without Cerebral Disease as Cause of Hyponatremia in General Medical Wards

J. Maesaka, L. Imbriano, N. Miyawaki, 2018, The American journal of the medical sciences.

Application of established pathophysiologic processes brings greater clarity to diagnosis and treatment of hyponatremia

J. Maesaka, L. Imbriano, N. Miyawaki, 2017, World journal of nephrology.

More on renal salt wasting without cerebral disease: response to saline infusion.

S. Fishbane, J. Maesaka, L. Imbriano, 2009, Clinical journal of the American Society of Nephrology : CJASN.

Atypical Presentations

S. Shirazian, J. Maesaka, L. Imbriano, 2022, Diabetes and Kidney Disease.

Anemia treatment in chronic kidney disease accompanied by diabetes mellitus or congestive heart failure.

S. Fishbane, N. Miyawaki, 2010, Kidney international.

Angiopoietin-1 upregulation by vascular endothelial growth factor in human retinal pigment epithelial cells.

J. Lim, M. Hangai, D. Hinton, 2001, Investigative ophthalmology & visual science.

Renal salt wasting without cerebral disease: diagnostic value of urate determinations in hyponatremia.

S. Fishbane, J. Maesaka, T. Palaia, 2007, Kidney international.

New Approach to Hyponatremia: High Prevalence of Cerebral/Renal Salt Wasting, Identification of Natriuretic Protein That Causes Salt Wasting

J. Maesaka, L. Imbriano, N. Miyawaki, 2022, Journal of clinical medicine.

Risk for Acute Renal Failure in Patients Hospitalized for Decompensated Congestive Heart Failure

S. Fishbane, N. Miyawaki, Harini Chittineni, 2007, American Journal of Nephrology.

Hypothesis: an erythropoietin honeymoon phase exists.

L. Szczech, S. Fishbane, N. Miyawaki, 2010, Kidney international.

Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A

J. Mattana, S. Carsons, L. Kasselman, 2019, Inflammation Research.

Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.

J. Maesaka, L. Imbriano, N. Miyawaki, 2012, Journal of nephrology.

Macrophage lipid accumulation in the presence of immunosuppressive drugs mycophenolate mofetil and cyclosporin A

J. Mattana, S. Carsons, L. Kasselman, 2019, Inflammation Research.

J. Maesaka, L. Imbriano, N. Miyawaki, 2023, Biomolecules.

Complexity of Differentiating Cerebral-Renal Salt Wasting from SIADH, Emerging Importance of Determining Fractional Urate Excretion

J. Maesaka, L. Imbriano, N. Miyawaki, 2012 .

Chronic kidney disease-associated pruritus: impact on quality of life and current management challenges

N. Miyawaki, Olufemi B Aina, Linle Hou, 2017, International journal of nephrology and renovascular disease.

Complexity of Differentiating Cerebral-Renal Salt Wasting from SIADH, Emerging Importance of Determining Fractional Urate Excretion

J. Maesaka, L. Imbriano, N. Miyawaki, 2012 .

High prevalence of renal salt wasting induced by haptoglobin-related protein without signal peptide is linked to new syndrome of salt wasting in Alzheimer disease.

J. Maesaka, L. Imbriano, N. Miyawaki, 2023, Kidney research and clinical practice.

Normal fractional urate excretion identifies hyponatremic patients with reset osmostat.

J. Maesaka, L. Imbriano, N. Miyawaki, 2012, Journal of nephrology.

2-D Models for Flows in the River with Submerged Groins

I. Fujita, Shirou Aya, N. Miyawaki, 1997 .